Family Medicine notes
7.95K subscribers
249 photos
16 videos
647 files
89 links
🆓 Educational notes to medical students, interns, family physicians & any health-care worker who is interested in helping patients efficiently
Download Telegram
👨🏻‍⚕️A real case from the clinic

30-year-old male with chronic Obesity (BMI 31).
He has done random labs and it shows the following:

Labs:
• TSH 7.3
• Free T4 = 0.75 ng/dl [N 0.70 – 1.48]
• Free T3 = 3.04 pg/ml [N 1.88 – 3.18]
• HbA1C & lipid profile (normal)

What is this condition?
How would you manage it?

(based on your questions, I will post more information)
4
Family Medicine notes
👨🏻‍⚕️A real case from the clinic 30-year-old male with chronic Obesity (BMI 31). He has done random labs and it shows the following: Labs: • TSH 7.3 • Free T4 = 0.75 ng/dl [N 0.70 – 1.48] • Free T3 = 3.04 pg/ml [N 1.88 – 3.18] • HbA1C & lipid profile (normal)…
Follow-up

Not diagnosed previously with hypothyroidism
Not on any meds or supplement

Hx: unspecified symptoms (fatigue, Obesity, anxiety, insomnia, constipation)

FHx: 3 family members of hypothyroidism (1st degree relatives)

These labs are not the first time
TSH is always high like this

What would you do next?
3
👨🏻‍⚕️A real case from the clinic (with changes)

A 47-year-old male with chronic history of DM, HTN & DLP

Medications:
- Metformin XR 750 mg OD
- Dapagliflozin 10 mg OD
- Gliclazide 30 mg OD
- Valsartan 160 mg OD
- Amlodipine 10 mg OD
- Bisoprolol 5 mg OD
- Rosuvastatin 20 mg OD
- Fenofibrate 145 mg OD

C/O few weeks hx of on/off feeling of hotness in his face
so he expose it to cold water to be relieved

What do you think that is?
And What is the most likely cause?

(write your answers below👇🏻)
10👍1
دورة تكنولوجيا السكري 2025

تعرف على:

🔺أحدث أنظمة مراقبة الجلوكوز المستمرة ومضخات الإنسولين.
🔺تعلم كيفية تحليل بيانات AGP بثقة وتحليل تقارير مضخات الإنسولين.
🔺تعلم أنماط هبوط وارتفاع السكر والمنحنيات ودلالاتها.
🔺ستتمكن من تطبيق أهداف الوقت في النطاق (TIR).
🔺أمثلة لحالات حقيقية وكيفية التعامل معها.
🔺فرصة للتفاعل في جلسة أسئلة وأجوبة مع خبراء تكنولوجيا السكري.

📅التاريخ: 2025/07/29
📍يوم الأربعاء
⁦ 8:00 ⁩ - ⁦ 10:30 ⁩ مساءً
📲 أونلاين وستكون مسجلة ومتاحة بالموقع

يوجد شهادة حضور

‏للتسجيل عبر الرابط:

خصم 20% عند إدخال كود AB

https://vistamed.osarh.pro/lesson/4/tech

Ad
5
1
A previously healthy 42-year-old man presented with a 20-day history of an expanding, asymptomatic rash on his trunk. The initial lesion had been a red spot on the patient’s left side. 10 days after that spot had first appeared, smaller lesions had developed elsewhere. The patient reported no viral prodrome. The skin examination — including the initial lesion that had appeared — is shown. What is the diagnosis?
Family Medicine notes
A previously healthy 42-year-old man presented with a 20-day history of an expanding, asymptomatic rash on his trunk. The initial lesion had been a red spot on the patient’s left side. 10 days after that spot had first appeared, smaller lesions had developed…
ANSWER: Pityriasis rosea (P.rosea)

On the basis of the finding of a “herald” patch in the patient’s midaxillary line on the left side, a diagnosis of pityriasis rosea was made. Pityriasis rosea is a self-limiting disorder that typically affects children, adolescents, and young adults. The cause of pityriasis rosea remains unclear. It may be related to viral reactivation of human herpes virus 6 or 7.

© NEJM image challenge
8
2026_acc_aha_aacvpr_abc_acpm_ada_ags_apha_aspc_nla_pcna_guideline.pdf
21.7 MB
🆕 2026 ACC/AHA Guideline on the Management of Dyslipidemia (DLP)
1👍1
Primary Prevention in Adults 30-79

🤯 You could start STATIN if PREVENT score is as low as 3 !!!

📌 LDL of 160 could justify starting of Tx!

🆕 2026 Dyslipidemia (DLP) AHA/ACC guideline
3👍1
Managing dyslipidemia (DLP) in patients with diabetes (DM)

📌 Not only those above 40, but as low as 20-year-old if has risk enhancers!

🆕 2026 Dyslipidemia (DLP) AHA/ACC guideline
👍2
Causes and management of Hypertriglyceridemia (↑ TG)

📌 Still you need to focus on ASCVD reduction as a priority especially for non-severe hyperTG

🆕 2026 Dyslipidemia (DLP) AHA/ACC guideline
2